Famotidine Powder, For Suspension
Product Images NDC 72205-233

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 72205-233). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Famotifine-oral-sus-cntr-label (Famotifine Oral Sus Cntr Label)

Label for Famotidine for Oral Suspension, USP 40 mg/5 mL powder for suspension by Novadoz Pharmaceuticals LLC. The label specifies each 5 mL of reconstituted suspension contains 40 mg famotidine, with a 55 mL volume after reconstitution. Instructions for reconstitution and storage are included along with inactive ingredients and manufacturer information.*

FDA Label Image

Famotifine-oral-sus-structure (Famotifine Oral Sus Structure)

Chemical structure of famotidine showing its molecular components including sulfur, nitrogen, oxygen, and carbon atoms arranged in a specific configuration characteristic of its chemical identity.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.